Key result
AVP shows potential for hypotensive resuscitation in hemorrhagic shock but remains unproven as rescue therapy.
Why the study?
Does arginine vasopressin improve blood pressure and enable resuscitation in patients with hemorrhagic shock?
Does arginine vasopressin improve blood pressure and enable resuscitation in patients with hemorrhagic shock?
Arginine vasopressin shows promise in preclinical and case report data for hypotensive resuscitation in hemorrhagic shock, but definitive clinical evidence is still lacking.
No takes yet. Share an insight, caveat, or question.
Caution against routine use in hemorrhagic shock; leaves open efficacy pending prospective randomized trials.
Voelckel et al. (2010) conducted a review in Hemorrhagic shock. Arginine vasopressin (AVP) was evaluated. Arginine vasopressin shows potential for hypotensive resuscitation in hemorrhagic shock based on animal and case studies, but its efficacy as a rescue medication remains unproven.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: